20 articles
Elevated blood TMAO levels nearly triple the risk of fast-growing aortic aneurysms, offering a new biomarker for surgical timing decisions.
New research reveals how the diversity of bacteria in your mouth may predict longevity and cardiovascular health outcomes.
New technique transforms nasal cells into complex airway tissue models for studying respiratory diseases like cystic fibrosis.
New research identifies unique molecular signatures in gut lymph and blood that could transform digestive health monitoring.
Scientists identify GSDME as a master switch driving abdominal aortic aneurysms through vascular aging, opening new treatment paths.
A newly identified molecular glitch in MAML1 phase separation disrupts Notch signaling and causes ventricular septal defects.
Novel liposome therapy delivers miR-10a to atherosclerotic plaques, reprogramming inflammatory macrophages and reducing disease progression in mice.
Scientists found that boosting ApoM levels helps clear harmful cholesterol deposits that cause age-related vision loss and heart problems.
Scientists identify GPRASP1 as a key guardian of pulmonary vascular health, opening a potential drug target for PH-HFpEF.
New research shows knocking out the AhR receptor significantly reduces arterial plaque formation and improves cholesterol levels.
Poor dental hygiene and chronic sinus infections create inflammation that directly increases cardiovascular disease risk.
New research reveals how eliminating urokinase plasminogen activator can temporarily protect against diet-induced weight gain and metabolic dysfunction.
Myqorzo (aficamten) wins FDA approval for symptomatic obstructive HCM, offering a novel cardiac myosin inhibitor option for patients.
New research shows citrate supplementation restores blood vessel function and extends lifespan by improving mitochondrial health.
Researchers created synthetic immune receptors that boost macrophages' ability to clear cellular debris, reducing inflammation in liver and heart disease.
New research reveals how blood vessel dysfunction leads to dangerous aortic aneurysms through immune cell activation.
12-week vitamin D treatment reduced IBD inflammation by promoting immune tolerance to beneficial gut bacteria through multiple pathways.
New research reveals how GRK2 protein clumping damages brain cells and identifies potential therapeutic targets to slow cognitive decline.
Elevated oxidized phospholipids independently predict major cardiac events after ACS, and alirocumab abolishes that risk signal.
Dr. Jamnadas reveals how 100 trillion gut bacteria influence thoughts, inflammation, fatty liver, and heart disease through the gut-brain axis.
